Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Troeger, C.
Right arrow Articles by Hahn, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Troeger, C.
Right arrow Articles by Hahn, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 5, No. 12, 1162-1165, December 1999
© 1999 European Society of Human Reproduction and Embryology


Diagnosing genetic disease

Approximately half of the erythroblasts in maternal blood are of fetal origin

C. Troeger1, X.Y. Zhong1, R. Burgemeister2, S. Minderer2, S. Tercanli1, W. Holzgreve1 and S. Hahn1,3

1 Laboratory for Prenatal Medicine, Department of Obstetrics and Gynaecology, University of Basel, Schanzenstrasse 46, 4031 Basel, Switzerland, and 2 Pränatal-Medizin München, Frauenärzte und Genetik, Lachnerstrasse 20, 80639 Munich, Germany

Abstract

The enrichment of fetal erythroblasts from the peripheral blood of pregnant women is currently actively pursued for the development of a non-invasive means of prenatal diagnosis. Since erythroblasts in maternal blood are not all of fetal origin, and currently no reliable method exists to distinguish between the maternal and fetal erythroblasts, their use for prenatal diagnosis is not without uncertainty. The purpose of this study was to determine the percentage of fetal erythroblasts in maternal blood at the single cell level and to what extent such cells can reproducibly be used for polymerase chain reaction (PCR)-based prenatal diagnostic analyses. Erythroblasts were enriched from the peripheral blood of rhesus negative pregnant women using magnetic cell sorting (MACS). Single erythroblasts identified morphologically were individually micromanipulated and analysed by a multiplex PCR reaction for the fetal SRY and rhesus D genes. As a control for the PCR reaction the ß-globin gene was used. The PCR results were validated by the results obtained by invasive procedures. In all instances where single erythroblasts were examined, the correct fetal genotype for the two fetal specific loci was detected. Furthermore, our results indicate that ~50% of the enriched erythroblasts are of fetal origin.

fetal erythroblasts/maternal blood/prenatal diagnosis/single cell PCR

Notes

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
J. Choe, D. Hwang, K.-C. Kim, and Y.-M. Choi
Fetal Gender Determination and BclI Polymorphism Using Nucleated Erythrocytes in Maternal Blood
J. Histochem. Cytochem., March 1, 2005; 53(3): 323 - 327.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. Fernandez, B. Prieto, A. Escudero, J. H. Ladenson, and F. V. Alvarez
A Monoclonal Antibody with Potential for Aiding Non-invasive Prenatal Diagnosis: Utility in Screening of Pregnant Women at Risk of Preeclampsia
J. Histochem. Cytochem., March 1, 2005; 53(3): 345 - 350.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
Y. Li, X. Y. Zhong, A. Kang, C. Troeger, W. Holzgreve, and S. Hahn
Inability to Detect Cell Free Fetal DNA in the Urine of Normal Pregnant Women nor in Those Affected by Preeclampsia Associated HELLP Syndrome
Reproductive Sciences, December 1, 2003; 10(8): 503 - 508.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
S. Hristoskova, W. Holzgreve, and S. Hahn
Fetal Nucleated Erythrocytes in Maternal Circulation Do Not Display a Classic Membrane-associated Apoptotic Characteristic (Phosphatidylserine Exposure) Despite Being Positive by Terminal dUTP Nuclear End Labeling
Clin. Chem., November 1, 2003; 49(11): 1934 - 1937.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
T. V. Hviid
In-Cell PCR Method for Specific Genotyping of Genomic DNA from One Individual in a Mixture of Cells from Two Individuals: A Model Study with Specific Relevance to Prenatal Diagnosis Based on Fetal Cells in Maternal Blood
Clin. Chem., December 1, 2002; 48(12): 2115 - 2123.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
X. Y. Zhong, W. Holzgreve, and S. Hahn
Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts
Mol. Hum. Reprod., September 1, 2002; 8(9): 864 - 870.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y.M. D. Lo, T. K. Lau, L. Y.S. Chan, T. N. Leung, and A. M.Z. Chang
Quantitative Analysis of the Bidirectional Fetomaternal Transfer of Nucleated Cells and Plasma DNA
Clin. Chem., September 1, 2000; 46(9): 1301 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
E. Di Naro, F. Ghezzi, A. Vitucci, N. Tannoia, D. Campanale, V. D'Addario, W. Holzgreve, and S. Hahn
Prenatal diagnosis of {beta}-thalassaemia using fetal erythroblasts enriched from maternal blood by a novel gradient
Mol. Hum. Reprod., June 1, 2000; 6(6): 571 - 574.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.